Department of Pharmacology and Pharmacotherapy, Section for Social Pharmacy, Faculty of Pharmaceutical Sciences, University of Copenhagen, FKL-Research Centre for Quality in Medicine Use, Copenhagen, Denmark.
Br J Clin Pharmacol. 2010 Oct;70(4):481-91. doi: 10.1111/j.1365-2125.2010.03682.x.
To review the literature on adverse drug reactions (ADRs) in children with respect to occurrence, seriousness, type, therapeutic group, age and gender of the child and category of reporter.
Medline and Embase databases were searched from origin and updated until February 2010. We included empirically based articles on ADRs in populations aged 0 to 17 years. Studies monitoring ADRs in patients with particular conditions or drug exposure were excluded. We extracted information about types and seriousness of ADRs, therapeutic groups, age and gender of the child and category of reporter. ADR occurrence was calculated as incidence rate and prevalence.
We included 33 studies monitoring ADRs in general paediatric populations. The highest numbers of ADRs were reported in national ADR databases where data were collected over a longer period than in studies monitoring inpatients and outpatients. However, prevalence and incidence were much lower in the national databases. Types of reported ADRs, seriousness of ADRs and types of medicines differed substantially between studies due to differences in time periods and patient populations. Information about ADRs was mainly provided by health care professionals, although parents also contributed reports.
We found a higher incidence rate of ADRs in hospitalized children and outpatients than in national databases. There seems to be considerable potential for increasing the knowledge of ADRs by advocating the submission of reports to the spontaneous reporting systems. Our study underscores that ADRs in children constitute a significant public health problem.
回顾儿童药物不良反应(ADR)的文献,涉及发生率、严重程度、类型、治疗组、儿童年龄和性别以及报告者类别。
检索 Medline 和 Embase 数据库,检索范围为建库至 2010 年 2 月的所有文献。我们纳入了有关 0 至 17 岁人群中 ADR 的基于经验的文章。排除了监测特定疾病或药物暴露患者 ADR 的研究。我们提取了有关 ADR 类型和严重程度、治疗组、儿童年龄和性别以及报告者类别的信息。ADR 发生率计算为发生率和患病率。
我们纳入了 33 项监测一般儿科人群 ADR 的研究。在收集数据时间超过监测住院和门诊患者的国家 ADR 数据库中,报告的 ADR 数量最多。然而,国家数据库中的患病率和发生率要低得多。由于时间段和患者人群的差异,报告的 ADR 类型、ADR 的严重程度和药物类型在研究之间存在很大差异。ADR 信息主要由医疗保健专业人员提供,尽管父母也提供了报告。
我们发现住院和门诊儿童的 ADR 发生率高于国家数据库。通过倡导向自发报告系统提交报告,似乎有很大的潜力增加对 ADR 的认识。我们的研究强调了儿童 ADR 是一个重大的公共卫生问题。